Dr. Sonpavde is on Doximity
As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
OfficeDana Farber Cancer Institute
450 Brookline Ave, D924
Boston, MA 02215Phone(617) 632-2429Fax(617) 632-2165
- Is this information wrong?
Education & Training
- Indiana University School of MedicineFellowship, Hematology/Oncology, 1995 - 1998
- Nassau University Medical CenterResidency, Internal Medicine, 1992 - 1995
- Christian Medical College VelloreClass of 1990
Certifications & Licensure
- MA State Medical License 2017 - 2022
- AL State Medical License 2012 - 2017
- TX State Medical License 2003 - 2013
- AZ State Medical License 2001 - 2003
- TN State Medical License 1999 - 2002
- IN State Medical License 1995 - 1999
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
- Trial of Pembrolizumab for Advanced Penile Squamous Cell Carcinoma Start of enrollment: 2016 Jul 01Guru Sonpavde, MD
- Trial Using Gilotrif for Advanced Penile Squamous Cell Carcinoma Start of enrollment: 2015 Oct 01Dorff T.,Sonpavde G.
- A Study of Varlilumab (Anti-CD27) and Sunitinib in Patients With Metastatic Clear Cell Renal Cell Carcinoma Start of enrollment: 2015 May 01
- Study of Regorafenib for Urothelial Cancer Following Chemotherapy (UAB 1477) Start of enrollment: 2015 May 01Guru Sonpavde, MD
- Chemotherapy Before Surgery in Treating Patients With High Grade Upper Urinary Tract Cancer Start of enrollment: 2015 Apr 01Alva A.S.,Carlson J.W.,Clark P.E.,Gourdin T.S.,Gross H.M.,Hoffman-censits J.H.,Kessler E.R.,Margulis V.,Masters G.A.,Matrana M.R.,Muler J.H.,Qamar R.,Reynolds C.M.,Sonpavde G.P.,Stratton K.L.,Vadakara J.J...
- S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder Cancer Start of enrollment: 2014 Jul 01Carrizales, G.R.,Flaig, T.W.
- LHRH Analogue Therapy With Enzalutamide or Bicalutamide in Treating Patients With Metastatic Hormone Sensitive Prostate Cancer Start of enrollment: 2014 May 01Nabhan, C.,Sonpavde, G.P.,Monk, J.P.,Stein, M.N.,Tejwani, S.,Vaishampayan, U.N.,Vaishampayan, U.,Oh, W.K.
- Join now to see all
Publications & Presentations
- Real-world burden of illness and unmet need in locally advanced or metastatic urothelial carcinoma following discontinuation of PD-1/L1 inhibitor therapy: A Medicare c...Alicia K. Morgans, Zsolt Hepp, Sonali N Shah, Anne Shah, Allison Petrilla, Mary Small, Guru Sonpavde> ;Urologic Oncology-seminars and Original Investigations. 2021 Jul 5
- Identification of Somatic Gene Signatures in Circulating Cell-Free DNA Associated with Disease Progression in Metastatic Prostate Cancer by a Novel Machine Learning Pl...Edwin Lin, Andrew W. Hahn, Roberto Nussenzveig, Sergiusz Wesolowski, Nicolas Sayegh, Benjamin L. Maughan, Taylor Ryan McFarland, Nityam Rathi, Deepika Sirohi, Guru Son...> ;Oncologist. 2021 Jul 7
- Gene Expression Signature Correlates with Outcomes in Metastatic Renal Cell Carcinoma Patients Treated with Everolimus Alone or with a Vascular Disrupting AgentEddy S. Yang, Amin Nassar, Elio Adib, Opeyemi Jegede, Sarah Abou Alaiwi, Deborah L. Della Manna, David A. Braun, Mahsa Zarei, Heng Du, Sumanta K. Pal, Gurudatta Naik, ...> ;Molecular Cancer Therapeutics. 2021 Jun 9
- Join now to see all
- Development and Validation of a Prognostic Model for Overall Survival in Chemotherapy-Naïve Men with Metastatic Castration-Resistant Prostate CancerG Sonpavde, C S Higano, T M Beer, Annals of Oncology
- Treatment and Clinical Outcomes of Patients with Teratoma with Somatic-Type Malignant Transformation: An International CollaborationRichard S Foster, Lawrence H Einhorn, Christopher J Sweeney, Guru Sonpavde, Costantine Albany, Chandra K Flack, The Journal of Urology
- Nomogram to predict the benefit from salvage systemic therapy for advanced urothelial carcinoma.Sonpavde G, Pond GR, Fougeray R, Bellmunt J., BJU Int, 2014
- 5-factor prognostic model for survival of patients with metastatic urothelial carcinoma receiving three different post-platinum PD-L1 inhibitors.2019 ASCO Annual Meeting - 6/1/2019
- A phase 3 randomized study of neoadjuvant chemotherapy (NAC) alone or in combination with nivolumab (NIVO) Â± BMS-986205 in cisplatin-eligible muscle invasive bladder ...2019 ASCO Annual Meeting - 6/1/2019
- GU Updates Abound at ASCO 2021June 2021
- Cancer treatment: is a clinical trial right for youMarch 2019
- Immunotherapy for cancer therapy: What you need to knowJanuary 2019
- GU Updates Abound at ASCO 2021June 15th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: